Skip to main content

LENZ Therapeutics, Inc.

LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815776

No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in LENZ Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
63
+1 vs. Q1 2022
Shares held
30.2M
−6.19M (−17.0%) vs. Q1 2022
Total value
$83.0M
−$102.6M (−55.3%) vs. Q1 2022
New holders
29
11 more added
Sold out
28
14 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 63 institutions
Q1 2021: 0 institutionsQ2 2021: 51 institutionsQ3 2021: 60 institutionsQ4 2021: 58 institutionsQ1 2022: 63 institutionsQ2 2022: 63 institutionsQ3 2022: 63 institutionsQ4 2022: 66 institutionsQ1 2023: 62 institutionsQ2 2023: 66 institutionsQ3 2023: 67 institutionsQ4 2023: 63 institutionsQ1 2024: 55 institutionsQ2 2024: 65 institutionsQ3 2024: 78 institutionsQ4 2024: 95 institutionsQ1 2025: 105 institutionsQ2 2025: 114 institutionsQ3 2025: 166 institutionsQ4 2025: 161 institutionsQ1 2026: 146 institutionsQ2 2026: 145 institutions
Value heldQ2 2022: $83.0M
Q1 2021: $0Q2 2021: $1.01BQ3 2021: $587.4MQ4 2021: $442.2MQ1 2022: $185.7MQ2 2022: $83.0MQ3 2022: $93.9MQ4 2022: $95.6MQ1 2023: $72.9MQ2 2023: $81.2MQ3 2023: $75.8MQ4 2023: $84.2MQ1 2024: $363.3MQ2 2024: $327.1MQ3 2024: $444.9MQ4 2024: $573.2MQ1 2025: $541.8MQ2 2025: $726.4MQ3 2025: $1.36BQ4 2025: $561.6MQ1 2026: $303.3MQ2 2026: $197.3M
Institutions holding LENZ and their total value by quarter
QuarterHoldersValue
Q2 2026145$197.3M
Q1 2026146$303.3M
Q4 2025161$561.6M
Q3 2025166$1.36B
Q2 2025114$726.4M
Q1 2025105$541.8M
Q4 202495$573.2M
Q3 202478$444.9M
Q2 202465$327.1M
Q1 202455$363.3M
Q4 202363$84.2M
Q3 202367$75.8M
Q2 202366$81.2M
Q1 202362$72.9M
Q4 202266$95.6M
Q3 202263$93.9M
Q2 202263$83.0M
Q1 202263$185.7M
Q4 202158$442.2M
Q3 202160$587.4M
Q2 202151$1.01B
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding LENZ in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Samsara BioCapital, LLC8,459,314$23.3M6.22%+386,711+4.8%Added
FMR LLC5,227,460$14.4M0.00%−2,013,000−27.8%Reduced
Citadel Advisors LLC1,319,836$3.63M0.00%+65,142+5.2%Added
EcoR1 Capital, LLC1,162,179$3.20M0.11%+137,900+13.5%Added
Tang Capital Management LLC1,100,000$3.02M0.46%+1,100,000New
Vanguard Group Inc1,063,911$2.93M0.00%−138,844−11.5%Reduced
Federated Hermes, Inc.1,056,308$2.90M0.01%00.0%Unchanged
OrbiMed Advisors LLC848,412$2.33M0.04%−717,400−45.8%Reduced
Renaissance Technologies LLC787,300$2.17M0.00%+787,300New
Morgan Stanley720,444$1.98M0.00%+157,810+28.0%Added
Avidity Partners Management LP710,000$1.95M0.04%00.0%Unchanged
Board of Trustees of The Leland Stanford Junior University703,071$1.93M0.13%00.0%Unchanged
Artal Group S.A.700,000$1.93M0.11%00.0%Unchanged
Laurion Capital Management LP573,600$1.58M0.07%+573,600New
Millennium Management LLC526,250$1.45M0.00%+402,461+325.1%Added
BlackRock Inc.488,008$1.34M0.00%−1,206,498−71.2%Reduced
Opaleye Management Inc.460,000$1.26M0.57%+204,500+80.0%Added
Two Sigma Investments, LP437,265$1.20M0.00%+437,265New
Goldman Sachs Group Inc418,081$1.15M0.00%+380,795+1,021.3%Added
OUP Management Co., LLC406,308$1.12M1.54%00.0%Unchanged
K2 Principal Fund, L.P.401,675$1.10M0.19%+401,675New
Privium Fund Management (UK) Ltd344,567$948.0K1.08%+344,567New
Woodline Partners LP300,031$825.0K0.01%00.0%Unchanged
Oasis Management Co Ltd.255,102$702.0K0.13%+255,102New
Two Sigma Advisers, LP239,700$659.0K0.00%+239,700New
Cormorant Asset Management, LP199,547$549.0K0.04%−3,606−1.8%Reduced
Geode Capital Management, LLC157,985$434.0K0.00%−259,033−62.1%Reduced
Ergoteles LLC131,000$360.0K0.01%+131,000New
Gsa Capital Partners LLP102,351$281.0K0.04%+102,351New
Cantor Fitzgerald, L. P.100,000$275.0K0.01%+100,000New
Acadian Asset Management LLC87,082$239.0K0.00%+87,082New
Cubist Systematic Strategies, LLC68,989$190.0K0.00%+52,767+325.3%Added
Simplex Trading, LLC69,089$189.0K0.01%+69,089New
Jump Financial, LLC55,917$154.0K0.01%+55,917New
Occudo Quantitative Strategies LP51,238$141.0K0.01%+51,238New
Marshall Wace, LLP50,648$139.0K0.00%+50,648New
Northern Trust Corp48,563$134.0K0.00%−198,153−80.3%Reduced
UBS Group AG48,222$132.0K0.00%+42,933+811.7%Added
State Street Corp47,451$130.0K0.00%−274,941−85.3%Reduced
D. E. Shaw & Co., Inc.47,049$129.0K0.00%+47,049New
Schonfeld Strategic Advisors LLC44,500$122.0K0.00%+44,500New
Bank of America Corp36,870$101.0K0.00%−27,341−42.6%Reduced
Prelude Capital Management, LLC24,457$67.0K0.00%+24,457New
Qube Research & Technologies Ltd17,643$49.0K0.00%+17,643New
Boothbay Fund Management, LLC14,045$39.0K0.00%+14,045New
StoneX Group Inc.13,700$37.7K0.00%+13,700New
Erste Asset Management GmbH11,900$33.3K0.00%00.0%Unchanged
Squarepoint Ops LLC11,749$32.0K0.00%+11,749New
LMR Partners LLP10,530$29.0K0.00%+10,530New
XTX Topco Ltd10,573$29.0K0.01%+10,573New
JPMorgan Chase & Co5,048$14.0K0.00%−15,474−75.4%Reduced
Citigroup Inc4,235$12.0K0.00%+1,848+77.4%Added
Cannell Capital LLC3,952$11.0K0.00%+3,952New
Wells Fargo & Company3,464$9.00K0.00%−6,733−66.0%Reduced
Advisor Group Holdings, Inc.3,070$9.00K0.00%+1,750+132.6%Added
Tower Research Capital LLC (TRC)716$2.00K0.00%−2,064−74.2%Reduced
New York State Common Retirement Fund290$1.00K0.00%−23,750−98.8%Reduced
Federation des caisses Desjardins du Quebec200$5500.00%00.0%Unchanged
American Portfolios Advisors20$550.00%−250−92.6%Reduced
Daiwa Securities Group Inc.169$00.00%00.0%Unchanged
Credit Suisse AG16$00.00%+16New
Ellevest, Inc.141$00.00%+141New
Steward Financial Group LLC13$00.00%+13New
Ra Capital Management, L.P.0$00.00%−2,698,369−100.0%Sold out
Rock Springs Capital Management LP0$00.00%−1,790,754−100.0%Sold out
VR Adviser, LLC0$00.00%−1,612,617−100.0%Sold out
Norges Bank0$00.00%−554,167−100.0%Sold out
Janus Henderson Group PLC0$00.00%−526,330−100.0%Sold out
Perceptive Advisors LLC0$00.00%−325,854−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−241,451−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−76,598−100.0%Sold out
Nuveen Asset Management, LLC0$00.00%−54,208−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−71,703−100.0%Sold out
Rhumbline Advisers0$00.00%−24,660−100.0%Sold out
MetLife Investment Management0$00.00%−20,146−100.0%Sold out
Deutsche Bank AG0$00.00%−16,539−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−14,964−100.0%Sold out
American International Group, Inc.0$00.00%−14,656−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−12,592−100.0%Sold out
California State Teachers Retirement System0$00.00%−12,630−100.0%Sold out
ProShare Advisors LLC0$00.00%−11,546−100.0%Sold out
Walleye Capital LLC0$00.00%−11,229−100.0%Sold out
Barclays PLC0$00.00%−8,779−100.0%Sold out
STRS Ohio0$00.00%−7,000−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−5,918−100.0%Sold out
Amalgamated Bank0$00.00%−4,182−100.0%Sold out
Legal & General Group Plc0$00.00%−2,830−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,360−100.0%Sold out
Royal Bank of Canada0$00.00%−1,813−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−1,246−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,028−100.0%Sold out
Amalgamated Financial Corp.––––Not filed